YI CHENG ZHI HUI LTD.
Update：2025/12/24
Industries
Main Industry
Health Care
Main Product/Service
AIxMed’s flagship solution, AIxURO™, is an AI-powered platform for urine cytology. It applies The Paris System for Reporting Urinary Cytology (TPS) to detect and classify atypical and suspicious cells, helping pathologists by offering quantitative risk an
Founded Year
2018
Unified Business No.
50894308
Status
Active
Number of Employees
0
Total Paid-in
Capital
0 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
AIxMed Inc., founded in 2018 and headquartered in Silicon Valley with a presence in Taiwan, is a health‑tech company that combines artificial intelligence with computational cytology. Their mission is to transform cancer diagnosis by applying machine lear
